Breaking News

Exco InTouch Appoint Ops VP

By Kristin Brooks | February 19, 2014

Burke brings 20 years of clinical research experience

Laurence Burke has been appointed vice president of operations at Exco InTouch. He joins the senior management team and will report to chief executive officer, Tim Davis. Mr. Burke will be responsible for ensuring that processes are streamlined and efficient for customers, as well as ensuring full continuity of robust delivery programs for operations in the clinical, late phase and mHealth fields. The operations team, including project management, support and logistics, will report to Mr. Burke based at the company’s Nottingham office. 
 
Mr. Burke brings more than 20 years of experience in clinical research within the pharmaceutical and technology service provider sectors, having previously held positions with Bayer, ClinPhone and PAREXEL. Mr. Burke is a Certified Project Management practitioner and a Lean Six Sigma Black Belt, with strong experience in building operational delivery and project support teams.
 
Mr. Davies said, “We are delighted that Laurence has joined Exco InTouch. We offer a range of products across the patient continuum so scale, turnaround and customer satisfaction are paramount. Consequently, utilizing the skill sets that Laurence possesses is a huge asset both to Exco InTouch, and our customers.”

Related Packaging:

blog comments powered by Disqus
  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision